Title
Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis
Comparison of the Healing of Chemotherapy-Induced Oral Mucositis Using Oral Defense Toothpaste Versus Crest Toothpaste and Magic Mouth Rinse
Phase
Phase 2Lead Sponsor
Oral Defense, LLCStudy Type
InterventionalStatus
TerminatedIntervention/Treatment
sodium fluoride lidocaine ...Study Participants
1The purpose of this study is to determine whether Oral Defense Toothpaste causes accelerated healing of chemotherapy-induced oral mucositis.
A pilot study showed that patients with chemotherapy-induced oral mucositis experienced accelerated healing of their oral mucositis by brushing with Oral Defense Toothpaste.
In this study, participants experiencing up to grade 2 chemotherapy-induced oral mucositis will be split into two arms. The first arm (test arm) will receive Oral Defense Toothpaste and be required to brush three times per day, for 8 days. The second arm (control arm) will receive Crest Toothpaste and be required to brush three times per day, for 8 days. Patients in the control arm will be provided Magic Mouth Rinse, if needed. Healing of oral mucositis lesions will be evaluated at days 1 and 8. Quality of life assessment (determination of pain/loss of oral function) will be determined using a daily questionnaire.
Brush with a Oral Defense Toothpaste three times per day during the study
Brush with Crest Toothpaste three times per day during the study
Participants using Crest Toothpaste who require additional pain intervention for their oral mucositis will be provided Magic Mouth Rinse
The experimental group will brush with Oral Defense Toothpaste three times per day during the study
The placebo group will brush with Crest Toothpaste three times per day during the study. Participants in the placebo comparator group who require additional management of their oral mucositis pain will be provided Magic Mouth Rinse.
Inclusion Criteria: Patients over the age of 18 receiving chemotherapy Mucositis lesions not exceeding grade 2 Exclusion Criteria: Patients receiving high load chemotherapy Patients receiving radiation therapy Patients receiving oral antivirals, oral antifungals or oral antibacterials Patients experiencing oral candidiasis